Taken together with the genotyping data, our results indicate that this transcriptionally inactive DKK2 allele was being selectively retained in the tumor when heterozygous HCC patients exhibited a LOH during tumorigenesis. The gene discussed is DKK2; the disease is hepatocellular carcinoma.